Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.
9don MSN
A fisherman is Jamaica's new bobsled pilot. He wants to make the team known beyond 'Cool Runnings'
CORTINA D'AMPEZZO, Italy (AP) — Monday would have been a fantastic day for fishing in Jamaica. The weather was just about perfect with bright sunshine, forecasters calling for temperatures in the ...
Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...
When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results